Shares of pharmaceutical companies fell across Europe and Asia after President Donald Trump said he planned to order a cut in ...

President Donald Trump said he plans to order a cut in US prescription drug costs by mandating that Americans pay no more ...

Takeda Pharmaceuticals delivered strong FY2024 results and offers value with a 4.81% yield, despite pressure from Vyvanse ...

Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

Takeda Pharmaceutical Co. (TAK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

Takeda will host an investor call on Sunday ... but it is to illustrate that as a global innovative pharmaceutical company, we have a very strong presence in the U.S., which is, by far today ...

Shares of Asian pharmaceutical companies fell after US President Donald Trump said he planned to order a cut in US ...

The U.S. president's social media post put pressure on drug-related stocks on worries their profits will take a hit if they ...

Indian pharmaceutical stocks fell sharply after U.S. President Donald Trump announced a push to lower domestic drug prices ...